Zepp Health Corporation Reports First Quarter of 2026 Unaudited Financial Results
StockNews.AI · 7 days
AI Summary
Zepp Health reported Q1 2026 revenue of $51.5m, up 33.8% year-over-year, with a 37.7% gross margin. It expanded its HYROX collaboration to a global 3-year wearable partnership and launched Balance 3/Ultra and Cheetah 2 devices, while broadening the Amazfit Athletes program. The company guided Q2 revenue to $63–$68m, signaling continued premiumization and growth despite ongoing profitability challenges.
Sentiment Rationale
Solid top-line growth, improving gross margins, strategic partnerships (HYROX) and a clear premium-product roadmap support a higher multiple through 2026. The share buyback adds a favorable cash-return signal, though net losses persist; investors may price in a multi-quarter recovery and margin expansion potential.
Trading Thesis
Bullish on ZEPP over 6–12 months driven by HYROX partnership and premium product cycle.
Market-Moving
- HYROX global exclusive 3-year wearable partnership enhances ecosystem and data integrations.
- Amazfit Balance 3/Ultra and Cheetah 2 launches support premiumization and user engagement.
- Q2 revenue guidance implies mid-teens growth prospects, offset by currency headwinds.
- Share repurchase extended through November 2026; ~$17m spent to date.
Key Facts
- Q1 2026 revenue $51.5m, +33.8% YoY; in line with guidance.
- Gross margin 37.7%, up 0.4pp YoY; RMB headwinds and entry-level mix cited.
- Cash $103.2m; inventory $62.8m; debt up $11.8m due to timing.
- Q2 2026 revenue guidance $63.0–$68.0m; HYROX global partnership extended.
Companies Mentioned
- Zepp Health Corporation (ZEPP): Reported Q1 2026 results; leads premium Amazfit ecosystem and HYROX collaboration.
- HYROX (HYROX): Exclusive three-year global wearable partnership; enhances training modes and participant access.
Earnings
Category: Earnings. The release centers on quarterly results and forward guidance, with strategic partnerships and product launches underscoring Zepp’s premiumization strategy within the wearables market.